fashion -WSS

fashion

author：Wikipedia 2025-08-23 08:56:22 - browse：866

Hyacinth Empinado/STAT

The body mass index, or BMI, is the formula that’s used most often to diagnose overweight and obesity. But unlike other common diagnoses, there is a certain stigma applied to people with a high body mass index, or BMI, which can affect how they are perceived by peers, providers, and society at large.

Despite the ubiquity of the BMI in medicine, many argue that it is a flawed tool, with a strange history. In recent months, the BMI has become more relevant than ever as the new semaglutide weight loss drugs are poised to change how obesity is understood and treated.

BMI is a simple calculation — a person’s weight in kilograms divided by the square of their height. But how BMI is then translated into a diagnosis is complicated and flawed.

Related: New weight loss drugs are changing the narrative on obesity, with a push from pharma

Watch this video to learn more about the history of the BMI — how it became so entrenched in medicine and, surprisingly, how its introduction may have set back decades of work on how obesity contributes to disease.

A STAT series is examining new obesity drugs that are transforming patients’ lives, dividing medical experts, and spurring one of the biggest business battles in years. Read more about The Obesity Revolution.

Previous article： After affirmative action ruling, medical educators look to 'holistic review'
Next article： Why Medicare shouldn’t cover every FDA

WSS

Hottest summer in 2,000 years puts focus on extreme heat, health

Abbott's new stent may help patients with peripheral artery disease

Cherokee Nation medical school graduates its first class

10 reasons why health care startups fail

Humana’s losses in Medicare Advantage tank its stock

Lilly’s weekly insulin works as well as daily products, new studies show

leisure time

fashion

Related: New weight loss drugs are changing the narrative on obesity, with a push from pharma

focus

Medical leaders decry Supreme Court decision on affirmative action

Lilly’s weekly insulin works as well as daily products, new studies show

BioMarin wins approval for gene therapy to treat hemophilia A

What a koala virus tells us about the human genome

Alkermes shareholders re

Obesity drug from Roche shows promise in early study

United colonoscopy coverage change 'may cost lives,' doctors say

Wegovy leads to weight loss. Can it treat depression, too?

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

As H5N1 spreads in cows, experts warn against drinking raw milk

explore

New clues to why women have higher risk of autoimmune disorders

Lilly’s weekly insulin works as well as daily products, new studies show

Hottest summer in 2,000 years puts focus on extreme heat, health

Boston hospital trains restaurant workers on naloxone for overdoses

Readout Newsletter: The latest on Novavax, Merck, Bluebird

Bernie Sanders is gearing up to subpoena pharma CEOs

hotspot

focus

hotspot

hotspot